Cargando…

Relation between autophagy and the resistence of glioblastoma cells to temozolomide

Detalles Bibliográficos
Autores principales:	Carmo, Anália, Carvalheiro, Helena, Lopes, Maria C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255016/

Ejemplares similares

Osteosarcoma contains a subpopulation of cancer stem-like cells that are highly resistant to radiotherapy
por: Neves, Sara RM, et al.
Publicado: (2010)

Indentification of cancer stem-like cells in osteosarcoma and their implications in response to chemotherapy
por: Lopes, Áurio O, et al.
Publicado: (2010)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma
por: Yu, Jian, et al.
Publicado: (2022)

GENETIC SCREENING REVEALS DEPENDENCY ON FEN1 TO RESIST TEMOZOLOMIDE IN TREATMENT-RESISTANT GLIOBLASTOMA STEM CELLS
por: Brakel, Benjamin, et al.
Publicado: (2023)

SOCS5 contributes to temozolomide resistance in glioblastoma by regulating Bcl-2-mediated autophagy
por: Yu, Jie, et al.
Publicado: (2022)

Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis
por: Buccarelli, Mariachiara, et al.
Publicado: (2018)

SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma
por: Chien, Chia-Hung, et al.
Publicado: (2022)

Metformin treatment reduces temozolomide resistance of glioblastoma cells
por: Yang, Seung Ho, et al.
Publicado: (2016)

Wnt/β-catenin signaling pathway induces autophagy-mediated temozolomide-resistance in human glioblastoma
por: Yun, Eun-Jin, et al.
Publicado: (2020)

Transferrin-Conjugated PLGA Nanoparticles for Co-Delivery of Temozolomide and Bortezomib to Glioblastoma Cells
por: Ramalho, Maria João, et al.
Publicado: (2023)

Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve
por: Koukourakis, Michael I, et al.
Publicado: (2016)

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
por: JIAPAER, Shabierjiang, et al.
Publicado: (2018)

ATP7B expression in human glioblastoma is related to temozolomide resistance
por: Moinuddin, F.M., et al.
Publicado: (2017)

Interrogating the interactions between myeloid derived suppressor cells and cancer stem cells in glioblastoma
por: Otvos, Balint, et al.
Publicado: (2013)

Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil
por: Almeida Lima, Karoline, et al.
Publicado: (2023)

Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma
por: Qu, Huiling, et al.
Publicado: (2020)

Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma
por: Zhao, Zijin, et al.
Publicado: (2021)

Integrins and p53 pathways in glioblastoma resistance to temozolomide
por: Martin, Sophie, et al.
Publicado: (2012)

Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review
por: Singh, Neha, et al.
Publicado: (2021)

Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma
por: Lo Dico, Alessia, et al.
Publicado: (2019)

Identification of copy number variations of chromosomes 7, 9 and 10 in human glioblastomas by SNP-arrays
por: Crespo, Inês, et al.
Publicado: (2010)

An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?
por: Teraiya, Milan, et al.
Publicado: (2023)

SPDR-05 PARP INHIBITORS RESTORE TEMOZOLOMIDE SENSITIVITY IN MSH6-DEFICIENT TEMOZOLOMIDE-RESISTANT GLIOBLASTOMA CELLS
por: Higuchi, Fumi, et al.
Publicado: (2019)

The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells
por: Mazor, Gal, et al.
Publicado: (2019)

Inhibition of O-GlcNAcylation Reduces Cell Viability and Autophagy and Increases Sensitivity to Chemotherapeutic Temozolomide in Glioblastoma
por: Leonel, Amanda V., et al.
Publicado: (2023)

Inhibition of Carbonic Anhydrase 2 Overcomes Temozolomide Resistance in Glioblastoma Cells
por: Zhao, Kai, et al.
Publicado: (2021)

Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastoma
por: Gong, Lingli, et al.
Publicado: (2022)

Myc-Foxo, a link between glutaminolysis and autophagy
por: Zola, Sheri, et al.
Publicado: (2012)

Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy. Comment on Strobel et al., Temozolomide and Other Alkylating Agents in Glioblastoma Therapy. Biomedicines 2019, 7, 69
por: Kaina, Bernd
Publicado: (2019)

Autophagy enhancement contributes to the synergistic effect of vitamin D in temozolomide-based glioblastoma chemotherapy
por: BAK, DONG-HO, et al.
Publicado: (2016)

Dovitinib enhances temozolomide efficacy in glioblastoma cells
por: Thanasupawat, Thatchawan, et al.
Publicado: (2017)

Molecular Mechanisms of KDELC2 on Glioblastoma Tumorigenesis and Temozolomide Resistance
por: Tsai, Yu-Ling, et al.
Publicado: (2020)

Gossypol Suppresses Growth of Temozolomide-Resistant Glioblastoma Tumor Spheres
por: Kim, Hee Yeon, et al.
Publicado: (2019)

Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
por: Wang, Chun, et al.
Publicado: (2023)

Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells
por: Harder, Bryan G., et al.
Publicado: (2019)

Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines
por: Sun, Stella, et al.
Publicado: (2011)

Role for Metallothionein-3 in the Resistance of Human U87 Glioblastoma Cells to Temozolomide
por: Santangelo, Rosa, et al.
Publicado: (2020)

Integrated genetic and metabolic landscapes predict vulnerabilities of temozolomide resistant glioblastoma cells
por: Immanuel, Selva Rupa Christinal, et al.
Publicado: (2021)

Novel cancer stem cell marker MVP enhances temozolomide-resistance in glioblastoma
por: Noh, Kum Hee, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dm5v8tg1jtehd24an8gjqt2ks6